nodes	percent_of_prediction	percent_of_DWPC	metapath
Oxprenolol—CYP2D6—Niacin—atherosclerosis	0.229	0.3	CbGbCtD
Oxprenolol—CYP2D6—Simvastatin—atherosclerosis	0.181	0.237	CbGbCtD
Oxprenolol—CYP2D6—Pravastatin—atherosclerosis	0.177	0.232	CbGbCtD
Oxprenolol—CYP2D6—Lovastatin—atherosclerosis	0.177	0.232	CbGbCtD
Oxprenolol—Diplopia—Pravastatin—atherosclerosis	0.00488	0.0242	CcSEcCtD
Oxprenolol—Orthostatic hypotension—Niacin—atherosclerosis	0.00452	0.0225	CcSEcCtD
Oxprenolol—Sweating increased—Pravastatin—atherosclerosis	0.00411	0.0204	CcSEcCtD
Oxprenolol—Arthralgia—Rosuvastatin—atherosclerosis	0.00349	0.0173	CcSEcCtD
Oxprenolol—Thrombocytopenia—Rosuvastatin—atherosclerosis	0.00328	0.0163	CcSEcCtD
Oxprenolol—Musculoskeletal discomfort—Rosuvastatin—atherosclerosis	0.00305	0.0151	CcSEcCtD
Oxprenolol—Insomnia—Rosuvastatin—atherosclerosis	0.00303	0.015	CcSEcCtD
Oxprenolol—Palpitations—Ezetimibe—atherosclerosis	0.00301	0.015	CcSEcCtD
Oxprenolol—Arthralgia—Lovastatin—atherosclerosis	0.00296	0.0147	CcSEcCtD
Oxprenolol—Dyspepsia—Rosuvastatin—atherosclerosis	0.00294	0.0146	CcSEcCtD
Oxprenolol—Arthralgia—Ezetimibe—atherosclerosis	0.0029	0.0144	CcSEcCtD
Oxprenolol—Thrombocytopenia—Lovastatin—atherosclerosis	0.00278	0.0138	CcSEcCtD
Oxprenolol—Arthralgia—Simvastatin—atherosclerosis	0.00277	0.0137	CcSEcCtD
Oxprenolol—Thrombocytopenia—Ezetimibe—atherosclerosis	0.00272	0.0135	CcSEcCtD
Oxprenolol—Abdominal pain—Rosuvastatin—atherosclerosis	0.00264	0.0131	CcSEcCtD
Oxprenolol—Palpitations—Niacin—atherosclerosis	0.00264	0.0131	CcSEcCtD
Oxprenolol—Thrombocytopenia—Simvastatin—atherosclerosis	0.0026	0.0129	CcSEcCtD
Oxprenolol—Musculoskeletal discomfort—Lovastatin—atherosclerosis	0.00258	0.0128	CcSEcCtD
Oxprenolol—Insomnia—Lovastatin—atherosclerosis	0.00256	0.0127	CcSEcCtD
Oxprenolol—Arthralgia—Niacin—atherosclerosis	0.00254	0.0126	CcSEcCtD
Oxprenolol—Musculoskeletal discomfort—Ezetimibe—atherosclerosis	0.00253	0.0126	CcSEcCtD
Oxprenolol—Insomnia—Ezetimibe—atherosclerosis	0.00252	0.0125	CcSEcCtD
Oxprenolol—Arthralgia—Pravastatin—atherosclerosis	0.0025	0.0124	CcSEcCtD
Oxprenolol—Dyspepsia—Lovastatin—atherosclerosis	0.0025	0.0124	CcSEcCtD
Oxprenolol—Hypersensitivity—Rosuvastatin—atherosclerosis	0.00246	0.0122	CcSEcCtD
Oxprenolol—Dyspepsia—Ezetimibe—atherosclerosis	0.00245	0.0122	CcSEcCtD
Oxprenolol—Fatigue—Lovastatin—atherosclerosis	0.00244	0.0121	CcSEcCtD
Oxprenolol—Musculoskeletal discomfort—Simvastatin—atherosclerosis	0.00242	0.012	CcSEcCtD
Oxprenolol—Asthenia—Rosuvastatin—atherosclerosis	0.0024	0.0119	CcSEcCtD
Oxprenolol—Insomnia—Simvastatin—atherosclerosis	0.0024	0.0119	CcSEcCtD
Oxprenolol—Fatigue—Ezetimibe—atherosclerosis	0.0024	0.0119	CcSEcCtD
Oxprenolol—Pruritus—Rosuvastatin—atherosclerosis	0.00237	0.0118	CcSEcCtD
Oxprenolol—Hyperhidrosis—Niacin—atherosclerosis	0.00235	0.0117	CcSEcCtD
Oxprenolol—Thrombocytopenia—Pravastatin—atherosclerosis	0.00235	0.0117	CcSEcCtD
Oxprenolol—Dyspepsia—Simvastatin—atherosclerosis	0.00233	0.0116	CcSEcCtD
Oxprenolol—Hyperhidrosis—Pravastatin—atherosclerosis	0.00232	0.0115	CcSEcCtD
Oxprenolol—Diarrhoea—Rosuvastatin—atherosclerosis	0.00229	0.0114	CcSEcCtD
Oxprenolol—Fatigue—Simvastatin—atherosclerosis	0.00229	0.0114	CcSEcCtD
Oxprenolol—Hypotension—Niacin—atherosclerosis	0.00228	0.0113	CcSEcCtD
Oxprenolol—Abdominal pain—Lovastatin—atherosclerosis	0.00224	0.0111	CcSEcCtD
Oxprenolol—Musculoskeletal discomfort—Niacin—atherosclerosis	0.00222	0.011	CcSEcCtD
Oxprenolol—Dizziness—Rosuvastatin—atherosclerosis	0.00221	0.011	CcSEcCtD
Oxprenolol—Insomnia—Niacin—atherosclerosis	0.0022	0.0109	CcSEcCtD
Oxprenolol—Abdominal pain—Ezetimibe—atherosclerosis	0.0022	0.0109	CcSEcCtD
Oxprenolol—Musculoskeletal discomfort—Pravastatin—atherosclerosis	0.00218	0.0109	CcSEcCtD
Oxprenolol—Insomnia—Pravastatin—atherosclerosis	0.00217	0.0108	CcSEcCtD
Oxprenolol—Dyspepsia—Niacin—atherosclerosis	0.00214	0.0106	CcSEcCtD
Oxprenolol—Dyspepsia—Pravastatin—atherosclerosis	0.00211	0.0105	CcSEcCtD
Oxprenolol—Abdominal pain—Simvastatin—atherosclerosis	0.0021	0.0104	CcSEcCtD
Oxprenolol—Headache—Rosuvastatin—atherosclerosis	0.0021	0.0104	CcSEcCtD
Oxprenolol—Hypersensitivity—Lovastatin—atherosclerosis	0.00209	0.0104	CcSEcCtD
Oxprenolol—Fatigue—Pravastatin—atherosclerosis	0.00207	0.0103	CcSEcCtD
Oxprenolol—Hypersensitivity—Ezetimibe—atherosclerosis	0.00205	0.0102	CcSEcCtD
Oxprenolol—Asthenia—Lovastatin—atherosclerosis	0.00203	0.0101	CcSEcCtD
Oxprenolol—Pruritus—Lovastatin—atherosclerosis	0.00201	0.00997	CcSEcCtD
Oxprenolol—Asthenia—Ezetimibe—atherosclerosis	0.002	0.00991	CcSEcCtD
Oxprenolol—Nausea—Rosuvastatin—atherosclerosis	0.00199	0.00987	CcSEcCtD
Oxprenolol—Pruritus—Ezetimibe—atherosclerosis	0.00197	0.00978	CcSEcCtD
Oxprenolol—Hypersensitivity—Simvastatin—atherosclerosis	0.00195	0.00971	CcSEcCtD
Oxprenolol—Diarrhoea—Lovastatin—atherosclerosis	0.00194	0.00964	CcSEcCtD
Oxprenolol—Abdominal pain—Niacin—atherosclerosis	0.00192	0.00956	CcSEcCtD
Oxprenolol—Asthenia—Simvastatin—atherosclerosis	0.0019	0.00945	CcSEcCtD
Oxprenolol—Diarrhoea—Ezetimibe—atherosclerosis	0.0019	0.00945	CcSEcCtD
Oxprenolol—Abdominal pain—Pravastatin—atherosclerosis	0.0019	0.00942	CcSEcCtD
Oxprenolol—Pruritus—Simvastatin—atherosclerosis	0.00188	0.00932	CcSEcCtD
Oxprenolol—Dizziness—Lovastatin—atherosclerosis	0.00187	0.00932	CcSEcCtD
Oxprenolol—Dizziness—Ezetimibe—atherosclerosis	0.00184	0.00914	CcSEcCtD
Oxprenolol—Diarrhoea—Simvastatin—atherosclerosis	0.00181	0.00902	CcSEcCtD
Oxprenolol—Hypersensitivity—Niacin—atherosclerosis	0.00179	0.00891	CcSEcCtD
Oxprenolol—Headache—Lovastatin—atherosclerosis	0.00178	0.00882	CcSEcCtD
Oxprenolol—Hypersensitivity—Pravastatin—atherosclerosis	0.00177	0.00878	CcSEcCtD
Oxprenolol—Dizziness—Simvastatin—atherosclerosis	0.00175	0.00871	CcSEcCtD
Oxprenolol—Asthenia—Niacin—atherosclerosis	0.00175	0.00868	CcSEcCtD
Oxprenolol—Headache—Ezetimibe—atherosclerosis	0.00174	0.00866	CcSEcCtD
Oxprenolol—Pruritus—Niacin—atherosclerosis	0.00172	0.00856	CcSEcCtD
Oxprenolol—Asthenia—Pravastatin—atherosclerosis	0.00172	0.00855	CcSEcCtD
Oxprenolol—Pruritus—Pravastatin—atherosclerosis	0.0017	0.00843	CcSEcCtD
Oxprenolol—Nausea—Lovastatin—atherosclerosis	0.00168	0.00837	CcSEcCtD
Oxprenolol—Diarrhoea—Niacin—atherosclerosis	0.00167	0.00828	CcSEcCtD
Oxprenolol—Headache—Simvastatin—atherosclerosis	0.00166	0.00825	CcSEcCtD
Oxprenolol—Nausea—Ezetimibe—atherosclerosis	0.00165	0.00821	CcSEcCtD
Oxprenolol—Diarrhoea—Pravastatin—atherosclerosis	0.00164	0.00815	CcSEcCtD
Oxprenolol—Dizziness—Niacin—atherosclerosis	0.00161	0.008	CcSEcCtD
Oxprenolol—Dizziness—Pravastatin—atherosclerosis	0.00159	0.00788	CcSEcCtD
Oxprenolol—Nausea—Simvastatin—atherosclerosis	0.00158	0.00783	CcSEcCtD
Oxprenolol—Headache—Niacin—atherosclerosis	0.00153	0.00758	CcSEcCtD
Oxprenolol—Headache—Pravastatin—atherosclerosis	0.0015	0.00746	CcSEcCtD
Oxprenolol—Nausea—Niacin—atherosclerosis	0.00145	0.00719	CcSEcCtD
Oxprenolol—Nausea—Pravastatin—atherosclerosis	0.00142	0.00708	CcSEcCtD
Oxprenolol—SLC22A2—Metabolism—ABCG5—atherosclerosis	4.62e-05	0.00133	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—CCR2—atherosclerosis	4.6e-05	0.00133	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—EDNRA—atherosclerosis	4.6e-05	0.00133	CbGpPWpGaD
Oxprenolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CXCL8—atherosclerosis	4.59e-05	0.00132	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—CCR2—atherosclerosis	4.5e-05	0.0013	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—EDNRA—atherosclerosis	4.5e-05	0.0013	CbGpPWpGaD
Oxprenolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CXCL8—atherosclerosis	4.49e-05	0.00129	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—GHRL—atherosclerosis	4.48e-05	0.00129	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—LPA—atherosclerosis	4.46e-05	0.00129	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—PLTP—atherosclerosis	4.42e-05	0.00127	CbGpPWpGaD
Oxprenolol—ADRB1—GPCR ligand binding—CCL2—atherosclerosis	4.42e-05	0.00127	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—CCL4—atherosclerosis	4.4e-05	0.00127	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—GHRL—atherosclerosis	4.39e-05	0.00126	CbGpPWpGaD
Oxprenolol—ADRB1—GPCR downstream signaling—KNG1—atherosclerosis	4.33e-05	0.00125	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—BGN—atherosclerosis	4.32e-05	0.00124	CbGpPWpGaD
Oxprenolol—ADRB2—GPCR ligand binding—CCL2—atherosclerosis	4.32e-05	0.00124	CbGpPWpGaD
Oxprenolol—ADRB1—GPCR downstream signaling—AGTR1—atherosclerosis	4.31e-05	0.00124	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—CCL4—atherosclerosis	4.3e-05	0.00124	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—APOA5—atherosclerosis	4.28e-05	0.00123	CbGpPWpGaD
Oxprenolol—ADRB2—GPCR downstream signaling—KNG1—atherosclerosis	4.24e-05	0.00122	CbGpPWpGaD
Oxprenolol—ADRB2—GPCR downstream signaling—AGTR1—atherosclerosis	4.21e-05	0.00121	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—PLA2G1B—atherosclerosis	4.12e-05	0.00119	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—APOA2—atherosclerosis	4.11e-05	0.00118	CbGpPWpGaD
Oxprenolol—SLC22A2—Transmembrane transport of small molecules—PPARA—atherosclerosis	4.08e-05	0.00118	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—APOA2—atherosclerosis	4.02e-05	0.00116	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—ALOX5—atherosclerosis	3.98e-05	0.00115	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—KNG1—atherosclerosis	3.94e-05	0.00113	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—UTS2—atherosclerosis	3.92e-05	0.00113	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—AGTR1—atherosclerosis	3.91e-05	0.00113	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—KNG1—atherosclerosis	3.85e-05	0.00111	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—UTS2—atherosclerosis	3.84e-05	0.0011	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—LTA4H—atherosclerosis	3.83e-05	0.0011	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—ABCG8—atherosclerosis	3.83e-05	0.0011	CbGpPWpGaD
Oxprenolol—SLC22A2—Transmembrane transport of small molecules—APOA1—atherosclerosis	3.83e-05	0.0011	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—AGTR1—atherosclerosis	3.83e-05	0.0011	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—CX3CR1—atherosclerosis	3.76e-05	0.00108	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—CASR—atherosclerosis	3.76e-05	0.00108	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—CX3CL1—atherosclerosis	3.69e-05	0.00106	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—CX3CR1—atherosclerosis	3.68e-05	0.00106	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—CASR—atherosclerosis	3.68e-05	0.00106	CbGpPWpGaD
Oxprenolol—ADRB1—GPCR downstream signaling—EDN1—atherosclerosis	3.65e-05	0.00105	CbGpPWpGaD
Oxprenolol—ADRB1—GPCR downstream signaling—CCL5—atherosclerosis	3.62e-05	0.00104	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—CX3CL1—atherosclerosis	3.61e-05	0.00104	CbGpPWpGaD
Oxprenolol—ADRB2—GPCR downstream signaling—EDN1—atherosclerosis	3.57e-05	0.00103	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—NAMPT—atherosclerosis	3.57e-05	0.00103	CbGpPWpGaD
Oxprenolol—ADRB2—GPCR downstream signaling—CCL5—atherosclerosis	3.55e-05	0.00102	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—LIPC—atherosclerosis	3.55e-05	0.00102	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—APOC3—atherosclerosis	3.52e-05	0.00101	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—LDLR—atherosclerosis	3.5e-05	0.00101	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—CNR2—atherosclerosis	3.49e-05	0.00101	CbGpPWpGaD
Oxprenolol—ADRB1—GPCR ligand binding—CXCL8—atherosclerosis	3.49e-05	0.00101	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—MMP3—atherosclerosis	3.49e-05	0.001	CbGpPWpGaD
Oxprenolol—ADRB1—GPCR downstream signaling—PRKCG—atherosclerosis	3.45e-05	0.000992	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—CETP—atherosclerosis	3.42e-05	0.000985	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—CNR2—atherosclerosis	3.42e-05	0.000985	CbGpPWpGaD
Oxprenolol—ADRB2—GPCR ligand binding—CXCL8—atherosclerosis	3.42e-05	0.000984	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—MMP3—atherosclerosis	3.41e-05	0.000982	CbGpPWpGaD
Oxprenolol—ADRB2—GPCR downstream signaling—PRKCG—atherosclerosis	3.37e-05	0.000971	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—EDN1—atherosclerosis	3.32e-05	0.000955	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—CCL5—atherosclerosis	3.29e-05	0.000948	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—SCARB1—atherosclerosis	3.28e-05	0.000943	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—EDN1—atherosclerosis	3.24e-05	0.000934	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—CCL5—atherosclerosis	3.22e-05	0.000927	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—PRKCG—atherosclerosis	3.13e-05	0.000901	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—VWF—atherosclerosis	3.12e-05	0.000897	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—APOC3—atherosclerosis	3.1e-05	0.000892	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—HMGCR—atherosclerosis	3.09e-05	0.000891	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—LDLR—atherosclerosis	3.08e-05	0.000886	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—PRKCG—atherosclerosis	3.06e-05	0.000881	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—VWF—atherosclerosis	3.05e-05	0.000878	CbGpPWpGaD
Oxprenolol—SLC22A2—Transmembrane transport of small molecules—ALB—atherosclerosis	3.03e-05	0.000873	CbGpPWpGaD
Oxprenolol—ADRB1—GPCR downstream signaling—AGT—atherosclerosis	3.03e-05	0.000873	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—ABCG1—atherosclerosis	3.03e-05	0.000873	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—APOC3—atherosclerosis	3.03e-05	0.000872	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—LDLR—atherosclerosis	3.01e-05	0.000867	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—CCL3—atherosclerosis	3.01e-05	0.000866	CbGpPWpGaD
Oxprenolol—ADRB2—GPCR downstream signaling—AGT—atherosclerosis	2.97e-05	0.000854	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—CCL3—atherosclerosis	2.94e-05	0.000847	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—NCF1—atherosclerosis	2.88e-05	0.000829	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—LCAT—atherosclerosis	2.85e-05	0.000821	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—FABP4—atherosclerosis	2.85e-05	0.000821	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—NCF1—atherosclerosis	2.82e-05	0.000811	CbGpPWpGaD
Oxprenolol—ADRB1—GPCR downstream signaling—F2—atherosclerosis	2.8e-05	0.000807	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—APOA4—atherosclerosis	2.8e-05	0.000806	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—ABCA1—atherosclerosis	2.76e-05	0.000794	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—AGT—atherosclerosis	2.75e-05	0.000793	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—CYP7A1—atherosclerosis	2.75e-05	0.000791	CbGpPWpGaD
Oxprenolol—ADRB2—GPCR downstream signaling—F2—atherosclerosis	2.74e-05	0.000789	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—CCR2—atherosclerosis	2.72e-05	0.000783	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—EDNRA—atherosclerosis	2.72e-05	0.000783	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—CYBA—atherosclerosis	2.71e-05	0.000779	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—AGT—atherosclerosis	2.69e-05	0.000776	CbGpPWpGaD
Oxprenolol—ADRB1—GPCR downstream signaling—PIK3CG—atherosclerosis	2.68e-05	0.000772	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—CCR2—atherosclerosis	2.66e-05	0.000766	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—EDNRA—atherosclerosis	2.66e-05	0.000766	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—PLAT—atherosclerosis	2.65e-05	0.000763	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—GHRL—atherosclerosis	2.65e-05	0.000763	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—PARP1—atherosclerosis	2.65e-05	0.000763	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—CYBA—atherosclerosis	2.65e-05	0.000762	CbGpPWpGaD
Oxprenolol—ADRB2—GPCR downstream signaling—PIK3CG—atherosclerosis	2.62e-05	0.000755	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—PLAT—atherosclerosis	2.59e-05	0.000746	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—GHRL—atherosclerosis	2.59e-05	0.000746	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—PARP1—atherosclerosis	2.59e-05	0.000746	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—F2—atherosclerosis	2.54e-05	0.000733	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—CYP27A1—atherosclerosis	2.54e-05	0.000732	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—F2—atherosclerosis	2.49e-05	0.000717	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—PIK3CG—atherosclerosis	2.43e-05	0.000701	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—APOA2—atherosclerosis	2.41e-05	0.000694	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—PLA2G2A—atherosclerosis	2.41e-05	0.000694	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—ALOX5AP—atherosclerosis	2.41e-05	0.000694	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—ALOX15—atherosclerosis	2.41e-05	0.000694	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—PIK3CG—atherosclerosis	2.38e-05	0.000686	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—ABCG5—atherosclerosis	2.38e-05	0.000685	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—HMOX1—atherosclerosis	2.37e-05	0.000681	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—KNG1—atherosclerosis	2.32e-05	0.00067	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—AGTR1—atherosclerosis	2.31e-05	0.000666	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—LPA—atherosclerosis	2.3e-05	0.000662	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—KNG1—atherosclerosis	2.27e-05	0.000655	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—CCL2—atherosclerosis	2.27e-05	0.000653	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—APOB—atherosclerosis	2.27e-05	0.000653	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—AGTR1—atherosclerosis	2.26e-05	0.000651	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—PLG—atherosclerosis	2.25e-05	0.000649	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—BGN—atherosclerosis	2.22e-05	0.000641	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—CCL2—atherosclerosis	2.22e-05	0.000639	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—GSTM1—atherosclerosis	2.2e-05	0.000635	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—PLG—atherosclerosis	2.2e-05	0.000634	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—APOA5—atherosclerosis	2.2e-05	0.000634	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—LPL—atherosclerosis	2.16e-05	0.000623	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—SOCS3—atherosclerosis	2.13e-05	0.000614	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—PLA2G1B—atherosclerosis	2.12e-05	0.000611	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—GPX1—atherosclerosis	2.11e-05	0.000608	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—SOCS3—atherosclerosis	2.09e-05	0.000601	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—MMP3—atherosclerosis	2.06e-05	0.000593	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—CD36—atherosclerosis	2.06e-05	0.000592	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—IGF2—atherosclerosis	2.05e-05	0.000591	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—ALOX5—atherosclerosis	2.05e-05	0.00059	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—MMP3—atherosclerosis	2.01e-05	0.00058	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—IGF2—atherosclerosis	2.01e-05	0.000578	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—APOB—atherosclerosis	1.99e-05	0.000573	CbGpPWpGaD
Oxprenolol—ADRB1—GPCR downstream signaling—CXCL8—atherosclerosis	1.97e-05	0.000568	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—EDN1—atherosclerosis	1.96e-05	0.000564	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—MTHFR—atherosclerosis	1.95e-05	0.000561	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—APOB—atherosclerosis	1.95e-05	0.000561	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—CCL5—atherosclerosis	1.94e-05	0.00056	CbGpPWpGaD
Oxprenolol—ADRB2—GPCR downstream signaling—CXCL8—atherosclerosis	1.93e-05	0.000556	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—EDN1—atherosclerosis	1.92e-05	0.000552	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—PPARA—atherosclerosis	1.91e-05	0.00055	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—CCL5—atherosclerosis	1.9e-05	0.000548	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—LPL—atherosclerosis	1.9e-05	0.000547	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—LPL—atherosclerosis	1.86e-05	0.000536	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—AGT—atherosclerosis	1.85e-05	0.000533	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—PRKCG—atherosclerosis	1.85e-05	0.000532	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—NAMPT—atherosclerosis	1.84e-05	0.000529	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—LIPC—atherosclerosis	1.82e-05	0.000526	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—APOC3—atherosclerosis	1.81e-05	0.000522	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—APOE—atherosclerosis	1.81e-05	0.000522	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—PRKCG—atherosclerosis	1.81e-05	0.000521	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—LDLR—atherosclerosis	1.8e-05	0.000519	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—SPP1—atherosclerosis	1.8e-05	0.000519	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—CAV1—atherosclerosis	1.8e-05	0.000517	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—APOA1—atherosclerosis	1.79e-05	0.000516	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—CXCL8—atherosclerosis	1.79e-05	0.000516	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—SPP1—atherosclerosis	1.76e-05	0.000507	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—CETP—atherosclerosis	1.76e-05	0.000507	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—CXCL8—atherosclerosis	1.75e-05	0.000505	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—SCARB1—atherosclerosis	1.69e-05	0.000486	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—PDGFB—atherosclerosis	1.67e-05	0.00048	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—PIK3CG—atherosclerosis	1.64e-05	0.000471	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—PDGFB—atherosclerosis	1.63e-05	0.000469	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—AGT—atherosclerosis	1.63e-05	0.000468	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—APOE—atherosclerosis	1.59e-05	0.000459	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—LEP—atherosclerosis	1.59e-05	0.000459	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—HMGCR—atherosclerosis	1.59e-05	0.000459	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—AGT—atherosclerosis	1.59e-05	0.000458	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—PPARG—atherosclerosis	1.58e-05	0.000455	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—CAV1—atherosclerosis	1.58e-05	0.000455	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—APOA1—atherosclerosis	1.58e-05	0.000454	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—APOE—atherosclerosis	1.56e-05	0.000449	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—LEP—atherosclerosis	1.56e-05	0.000449	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—INS—atherosclerosis	1.55e-05	0.000446	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—CAV1—atherosclerosis	1.54e-05	0.000445	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—APOA1—atherosclerosis	1.54e-05	0.000444	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—ESR1—atherosclerosis	1.52e-05	0.000438	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—F2—atherosclerosis	1.5e-05	0.000433	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—ESR1—atherosclerosis	1.49e-05	0.000429	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—F2—atherosclerosis	1.47e-05	0.000423	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—PIK3CG—atherosclerosis	1.44e-05	0.000414	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—ALB—atherosclerosis	1.42e-05	0.000409	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—ABCA1—atherosclerosis	1.42e-05	0.000409	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—PIK3CG—atherosclerosis	1.41e-05	0.000405	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—MAPK3—atherosclerosis	1.38e-05	0.000397	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—INS—atherosclerosis	1.36e-05	0.000392	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—NOS3—atherosclerosis	1.36e-05	0.000391	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—MAPK3—atherosclerosis	1.35e-05	0.000388	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—CCL2—atherosclerosis	1.34e-05	0.000386	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—INS—atherosclerosis	1.33e-05	0.000384	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—IGF1—atherosclerosis	1.32e-05	0.000379	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—CCL2—atherosclerosis	1.31e-05	0.000377	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—IGF1—atherosclerosis	1.29e-05	0.000371	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—SERPINE1—atherosclerosis	1.25e-05	0.00036	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—PTGS2—atherosclerosis	1.24e-05	0.000358	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—SERPINE1—atherosclerosis	1.22e-05	0.000352	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—HMOX1—atherosclerosis	1.22e-05	0.000351	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—NOS3—atherosclerosis	1.19e-05	0.000344	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—NOS3—atherosclerosis	1.17e-05	0.000336	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—APOB—atherosclerosis	1.17e-05	0.000336	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—GSTM1—atherosclerosis	1.13e-05	0.000327	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—LPL—atherosclerosis	1.11e-05	0.000321	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—GPX1—atherosclerosis	1.09e-05	0.000313	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—CXCL8—atherosclerosis	1.06e-05	0.000305	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—CD36—atherosclerosis	1.06e-05	0.000305	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—CXCL8—atherosclerosis	1.04e-05	0.000298	CbGpPWpGaD
Oxprenolol—ADRB1—GPCR downstream signaling—AKT1—atherosclerosis	1.02e-05	0.000295	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—IL6—atherosclerosis	1.01e-05	0.00029	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—MTHFR—atherosclerosis	1e-05	0.000289	CbGpPWpGaD
Oxprenolol—ADRB2—GPCR downstream signaling—AKT1—atherosclerosis	1e-05	0.000288	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—IL6—atherosclerosis	9.85e-06	0.000284	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—PPARA—atherosclerosis	9.84e-06	0.000283	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—MMP9—atherosclerosis	9.58e-06	0.000276	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—AGT—atherosclerosis	9.53e-06	0.000274	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—NFKB1—atherosclerosis	9.48e-06	0.000273	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—MMP9—atherosclerosis	9.37e-06	0.00027	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—APOE—atherosclerosis	9.34e-06	0.000269	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—MAPK8—atherosclerosis	9.31e-06	0.000268	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—AKT1—atherosclerosis	9.29e-06	0.000268	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—NFKB1—atherosclerosis	9.27e-06	0.000267	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—CAV1—atherosclerosis	9.25e-06	0.000266	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—APOA1—atherosclerosis	9.23e-06	0.000266	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—MAPK8—atherosclerosis	9.11e-06	0.000262	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—AKT1—atherosclerosis	9.09e-06	0.000262	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—VEGFA—atherosclerosis	8.6e-06	0.000248	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—STAT3—atherosclerosis	8.52e-06	0.000245	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—PIK3CG—atherosclerosis	8.42e-06	0.000243	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—VEGFA—atherosclerosis	8.41e-06	0.000242	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—STAT3—atherosclerosis	8.33e-06	0.00024	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—MAPK3—atherosclerosis	8.14e-06	0.000234	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—PPARG—atherosclerosis	8.13e-06	0.000234	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—INS—atherosclerosis	7.97e-06	0.00023	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—MAPK3—atherosclerosis	7.96e-06	0.000229	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—TGFB1—atherosclerosis	7.89e-06	0.000227	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—TGFB1—atherosclerosis	7.72e-06	0.000222	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—ALB—atherosclerosis	7.31e-06	0.000211	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—NOS3—atherosclerosis	6.99e-06	0.000201	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—PTGS2—atherosclerosis	6.4e-06	0.000184	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—AKT1—atherosclerosis	6.24e-06	0.00018	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—IL6—atherosclerosis	5.95e-06	0.000171	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—IL6—atherosclerosis	5.82e-06	0.000168	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—AKT1—atherosclerosis	5.49e-06	0.000158	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—AKT1—atherosclerosis	5.37e-06	0.000155	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—AKT1—atherosclerosis	3.21e-06	9.26e-05	CbGpPWpGaD
